These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 330149)

  • 1. [1-glutamine and dipropylacetic acid as subsidiary psychotropic agents in the treatment of psychiatric in-patients. Effect on the neuroleptic consumption].
    Cocchi R; Mastruzzo A; Ciccone A; Osvaldi ML
    Encephale; 1977; 3(2):121-32. PubMed ID: 330149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acupuncture, "vital" drugs and psychotropic agents in psychiatric patients. 50 cases].
    Cocchi R; Fusari A; Favuto F; Lorini G
    Minerva Med; 1978 Sep; 69(44):3003-9. PubMed ID: 362243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acupunctura, "vital" drugs and psychopharmacological agents in the treatment of psychiatric patients with deep depressive disorders, with considerations on the probable neurophysiological mechanisms of the synergism of action].
    Cocchi R; Fusari A; Lorini G; Roccia L
    Minerva Med; 1977 Jul; 68(33):2309-14. PubMed ID: 331140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proposal for the introduction of a new substance into hospital practice: dipropyl acetate sodium in the prevention and treatment of alcoholic delirium].
    Bonfiglio G; Falli S; Pacini A
    Minerva Med; 1977 Dec; 68(63):4233-45. PubMed ID: 340985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approach to a combined pharmacologic therapy of childhood hyperkinesis.
    Knobel M
    Behav Neuropsychiatry; 1974 Apr-1975 Mar; 6(1-12):87-90. PubMed ID: 4619768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sodium di-n-propylacetate: evaluation of its so-called psychotropic effect. A controlled study].
    Sommerbeck KW; Theilgaard A; Rasmussen KE; Løhren V; Gram L; Wulff K
    Ugeskr Laeger; 1977 May; 139(18):1069-73. PubMed ID: 324059
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the therapeutic action and side-effects of a new preparation of dipropylacetic acid].
    Gallassi R
    Clin Ter; 1977 Nov; 83(3):313-7. PubMed ID: 342177
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of n-dipropylacetate and L-glutamine on gamma amino-n-butyric acid levels in brains of rats intoxicated with ethanol.
    Abbondanza A; Cessi C
    Arch Sci Biol (Bologna); 1978; 62(1-4):77-82. PubMed ID: 122142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of choreic syndromes with sodium dipropylacetate].
    Piccinin G; Morocutti C; Urcioli R; Bernardi G
    Riv Neurol; 1977; 47(2):107-16. PubMed ID: 141095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical--pharmacological aspects of treatment with sodium di-n-propylacetate].
    Wulff K; Flachs H; Würtz-Jørgensen A; Gram L
    Ugeskr Laeger; 1977 May; 139(18):1059-64. PubMed ID: 324057
    [No Abstract]   [Full Text] [Related]  

  • 11. A syndrome from a possible GABA deficiency. Clinical-therapeutic report on 15 cases.
    Cocchi R
    Acta Psychiatr Belg; 1978; 78(2):407-24. PubMed ID: 354328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic exposure in bipolar outpatients in a research setting.
    Denicoff KD; Sollinger AB; Frye MA; Ali SO; Smith-Jackson EE; Leverich GS; Post RM
    Compr Psychiatry; 2000; 41(4):248-52. PubMed ID: 10929791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic-valproic acid combination in treatment of psychotic symptoms: a three-case report.
    Wassef A; Watson DJ; Morrison P; Bryant S; Flack J
    J Clin Psychopharmacol; 1989 Feb; 9(1):45-8. PubMed ID: 2565347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntington's disease: treatment with dipropylacetic acid and gamma-aminobutyric acid.
    Shoulson I; Kartzinel R; Chase TN
    Neurology; 1976 Jan; 26(1):61-3. PubMed ID: 128707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of pyknoleptic petit mal epilepsy and juvenile myoclonic epilepsy with dipropyl acetate (Deprakine). A pilot study of therapy-resistant patients during control of plasma concentration].
    Schroll M; Naestoft J; Lund M
    Ugeskr Laeger; 1977 May; 139(18):1073-7. PubMed ID: 404744
    [No Abstract]   [Full Text] [Related]  

  • 16. [Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].
    Fröscher W; Schulz HU; Gugler R
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun; 46(6):327-41. PubMed ID: 352872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sodium dipropyl acetate in the prevention of febrile convulsions in children].
    Galli V; Gatti G; Massolo F; Nalin A; Rozzi N; Tamborino G
    Acta Neurol (Napoli); 1977; 32(6):884-91. PubMed ID: 343515
    [No Abstract]   [Full Text] [Related]  

  • 18. [Double-blind study on the anti-convulsive effect of phenobarbital and valproate in the Lennox syndrome].
    Vassella F; Rüdeberg A; Da Silva V; Pavlincova E
    Schweiz Med Wochenschr; 1978 May; 108(19):713-6. PubMed ID: 347569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trial of a new antiepileptic drug, magnesium dipropyl acetate].
    de Pasquet EG; Gomensoro JB; de Bustos LF; Tenzer SM
    Acta Neurol Latinoam; 1973; 19(1-4):119-28. PubMed ID: 4619958
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term treatment of juvenile Huntington's chorea with dipropylacetic acid.
    Bachman DS; Butler IJ; McKhann GM
    Neurology; 1977 Feb; 27(2):193-7. PubMed ID: 138101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.